» Articles » PMID: 6425354

Modification of Interpretive Breakpoints for Netilmicin Disk Susceptibility Tests with Pseudomonas Aeruginosa

Overview
Specialty Microbiology
Date 1984 Mar 1
PMID 6425354
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Regression analysis of data correlating 30-micrograms netilmicin disk zone diameters with microdilution MICs, obtained by testing close-interval dilution steps, was performed with 77 selected strains of Pseudomonas aeruginosa, each tested in three independent laboratories. A zone of greater than or equal to 15 mm correlated with an MIC of less than or equal to 12 micrograms/ml (susceptible), and a zone of less than or equal to 12 mm correlated with an MIC of greater than 16 micrograms/ml (resistant). Additional disk tests were performed with 256 strains having known resistance mechanisms and 280 susceptible strains: the majority were appropriately categorized by these interpretive zone standards. The previously recommended standards of greater than or equal to 17 mm (MIC, less than or equal to 8.0 micrograms/ml) for the susceptible category inappropriately placed a significant number of truly susceptible P. aeruginosa strains in the intermediate category.

Citing Articles

Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.

Holbrook S, Garneau-Tsodikova S Microb Drug Resist. 2017; 24(7):1020-1030.

PMID: 29261405 PMC: 6154764. DOI: 10.1089/mdr.2017.0101.


Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae.

Kronvall G, Ringertz S, Karlsson I, Goransson E, Dornbusch K Antimicrob Agents Chemother. 1988; 32(10):1484-9.

PMID: 3263831 PMC: 175903. DOI: 10.1128/AAC.32.10.1484.


Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.

Barry A, Miller G, Thornsberry C, Hare R, Jones R, Lorber R Antimicrob Agents Chemother. 1987; 31(10):1514-8.

PMID: 3124731 PMC: 174981. DOI: 10.1128/AAC.31.10.1514.


Netilmicin disk susceptibility tests: effect of cations on the MIC correlates.

Barry A, Miller G, Hare R, Thornsberry C, Jones R Eur J Clin Microbiol. 1987; 6(4):416-7.

PMID: 3117533 DOI: 10.1007/BF02013098.

References
1.
Meyers B, Hirschman S, Wormser G, Siegel D . Pharmacokinetic study of netilmicin. Antimicrob Agents Chemother. 1977; 12(1):122-3. PMC: 352165. DOI: 10.1128/AAC.12.1.122. View

2.
Trestman I, Parsons J, Santoro J, Goodhart G, Kaye D . Pharmacology and efficacy of netilmicin. Antimicrob Agents Chemother. 1978; 13(5):832-6. PMC: 352339. DOI: 10.1128/AAC.13.5.832. View

3.
Siegel J, McCracken Jr G, Thomas M, Threlkeld N . Pharmacokinetic properties of netilmicin in newborn infants. Antimicrob Agents Chemother. 1979; 15(2):246-53. PMC: 352641. DOI: 10.1128/AAC.15.2.246. View

4.
Jones R, Barry A, Thornsberry C . Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks. Antimicrob Agents Chemother. 1980; 18(3):487-90. PMC: 284029. DOI: 10.1128/AAC.18.3.487. View

5.
Barry A, Thornsberry C, Jones R, Gerlach E . Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation. Am J Clin Pathol. 1981; 75(4):524-31. DOI: 10.1093/ajcp/75.4.524. View